CDC Newsroom

CDC Recommends Novavax COVID-19 Vaccine for Adolescents

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.

Read the original news at Centers for Disease Control and Prevention (CDC)

Related Articles

Back to top button